Glucuronidation yielding the acylglucuronide is the major human metabolic pathway of dabigatran. Four isomeric acylglucuronides of dabigatran were isolated and purified and the structure was confirmed by NMR analysis as the 1-O-acylglucuronide and the 2-O-, 3-O-, and 4-O-acylglucuronides. The purified 1-O-acylglucuronide and its isomeric rearrangement products revealed equipotent prolongation of the activated partial thromboplastin time compared to dabigatran. The 1-O-acylglucuronide, underwent acyl-migration in aqueous solution that yielded the 2-O-, 3-O-, and 4-O-acylglucuronides with an apparent half-life of 1 hr (37℃, pH 7.4). The glucuronidation of dabigatran was catalysed by human hepatic and intestinal microsomes with Km data of 180-255μM and 411-759μM, respectively. UDP-glucuronosyltransferases UGT1A9, 2B7 and 2B15 glucuronidated dabigatran and UGT2B15 was considered the major contributor. The involvement of 3 UGT enzymes and the lack of potent inhibition of dabigatran glucuronidation by several UGT inhibitors indicate a low risk of interaction by co-medications on dabigatran metabolism in the clinic.
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[Purpose] Reconstructed cultured human skin models have been paid attention as an alternative animal membrane for skin permeation test. Skin permeation test is a useful tool to develop and evaluate topical drug formulations and cosmetics. Recently, reconstructed cultured human skin models as well as animal and human cadaver skins have been utilized as skin membranes. In the present experiment, six kinds of reconstructed cultured human skin models were selected and morphological properties and permeation profiles of model compounds of and through the skin models were evaluated. [Methods] Seven substances were used as penetrants. Six kinds of reconstructed cultured human skin models, having different characteristics, were used. Permeability coefficients, diffusion and partition parameters were calculated from the obtained permeation profile of 7 compounds through the cultured membranes. Furthermore, histological observation for each sample was done using H.E. stained tissues and transmission electron microscopy.
[Results and Discussion] A few cultured human skin models showed a fairly good relationship to the permeability coefficient values through cadaver human skin. Partition parameters were different to those in cadaver human skin, whereas diffusion parameters in reconstructed cultured human skin models were almost the same to cadaver human skin. These results might be related to lipophilicity differences in stratum corneum between reconstructed cultured human skin models and human skin.
[Conclusions] Reconstructed cultured human skin models showed different skin permeation profiles, so that we should have a great attention to select a reconstructed cultured human skin model for the permeation test of drugs and cosmetic ingredients. 
